Showing results (51-60 of 74) with videos related to
Sort By:
Pageof 8
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2022
Defining a Core Data Set for the Economic Evaluation of Precision OncologySamantha Pollard, Deirdre Weymann, Brandon Chan, et al.Journal of Vascular and Interventional Radiology : JVIR|May 24, 2024
Combination and Optimal Sequencing of Systemic and Locoregional Therapies in Hepatocellular Carcinoma: Proceedings from the Society of Interventional Radiology Foundation Research Consensus PanelLindsay M Thornton, Nadine Abi-Jaoudeh, Howard J Lim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2020
Population-based Screening for BRAF V600E in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor PrognosisJenny E Chu, Benny Johnson, Laveniya Kugathasan, et al.JCO Precision Oncology|August 8, 2024
"I Just Assumed This Was Already Being Done": Canadian Patient Preferences for Enhanced Data Sharing for Precision OncologySamantha Pollard, Morgan Ehman, Anna Hermansen, et al.Human Pathology|April 29, 2014
ARID1A/BAF250a as a prognostic marker for gastric carcinoma: a study of 2 cohortsKimberly C Wiegand, Keiyan Sy, Steve E Kalloger, et al.Cancer Medicine|July 24, 2020
Evaluating the impact of universal Lynch syndrome screening in a publicly funded healthcare systemPetra W C Lee, Angela C Bedard, Setareh Samimi, et al.Cancer Medicine|May 17, 2018
Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian databaseHaider H Samawi, Hao-Wen Sim, Kelvin K Chan, et al.Cancer Treatment Reviews|March 16, 2023
Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in CanadaJason K Wong, Howard J Lim, Vincent C Tam, et al.Cancer Treatment Reviews|July 23, 2026
Expanding the path to cure - a narrative review on optimizing multimodality sequencing in HCCHoward J Lim, Arndt Vogel, Emma M Dune, et al.Therapeutic Advances in Medical Oncology|June 30, 2023
Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancerMélina Boutin, James T Topham, Harriet Feilotter, et al.Pageof 8